Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control

Folia Histochemica et Cytobiologica

Volumn 48, Issue 3, 2010, Pages 358-365

  Sands, Dorota ^a   Ołtarzewski, Mariusz ^a   Nowakowska, Anna ^a   Zybert, Katarzyna ^a  

^a INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

Conductivity; Cystic fibrosis; Newborns; Screening; Sweat test

Indexed keywords

CHLORIDE; PILOCARPINE;

ARTICLE; CLINICAL ARTICLE; CONDUCTANCE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; INTERMETHOD COMPARISON; NANODUCT; NEWBORN; NEWBORN SCREENING; PANCREAS INSUFFICIENCY; PREDICTION; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; SWEAT TEST;

EID: 78649625654     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-010-0044-9     Document Type: Article

References (22)

1. Sands D, Zybert K, Ołtarzewski M et al. Newborn screening for CF in Poland. Pediatr Pol. 2008;83(6):624-633.
2. Sands D, Piotrowski R, Nowakowska A, et al. Use of conductometric sweat test in diagnosis of cystic fibrosis in infants. Pediatr Pol. 2004;79(7):538-542.
3. Gibson LE, Cooke RE. Atest for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis. Pediatrics. 1959;23:158-161.
4. Shwahman H, Mahmoodian A, Neff RK. The sweat test: sodium and chloride values. J Pediatr. 1981;98:576-8
5. National Committee for Clinical Laboratory Standards. Sweat testing: sample collection and quantitative analysis; approved guideline. Publication No C34-A2. 2nd ed. Wayne, PA: NCCLS, 2000.
6. Lezana JL, Vargas MH, Karam-Bechara J, Aldana RS, Furuya MEY. Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects. J Cyst Fibros. 2003;2:1-7
7. Sweat Chek conductivity analyser product sheet. Available at URL http://www.wescor.com/biomedical/html/sweat-chek.html. Accessed March 22, 2010.
8. Barben J, Ammann RA, Metlagel, Schoeni MH. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr. 2005;146(2):159-62.
9. Heeley ME, Woolf DA, Heeley AF. Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis. Arch Dis Child. 2000;82(5):420-4.
10. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation consensus Panel. J Pediatr. 1998;132:589-595.
11. Taylor CJ, Hardcastle J, Southern KW. Physiological measurements confirming the diagnosis of cystic fibrosis: the sweat test and measurements of transepithelial potential difference. Paediatr Respir Rev. 2009;10(4):220-6.
12. Desax MC, Ammann RA, Hammer J, Schoeni MH, Barben J. Nanoduct sweat testing for rapid diagnosis of newborns, infants and children with cystic fibrosis. Eur J Pediatr. 2008; 167:299-304.
13. Jayaraj R, Barton PV, Newland P, Mountford R, Shaw NJ, McCarthy E, Isherwood DM, Southern KW. A reference interval for sweat chloride in infants aged between five and six weeks of age. Ann Clin Biochem. 2009;46(1):73-8.
14. Massie RJ, Olsen M, Glazner J, Robertson CF, Francis I. Newborn screening for cystic fibrosis in Victoria:10 years ' experience (1989-1998). Med J Aust. 2000;172:584-587.
15. Massie J, Clements B. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience -twenty years and five million babies later: a consensus statement from Australasian paediatric respiratory group. Pediatr Pulmonol. 2005;39:440-446.
16. Farrell PM, Koscik RE. Sweat chloride concentration in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics. 1996;97:524-528.
17. Farrell PM, Rosenstein BJ, White TB et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-S14.
18. Mackay RJ, Florkowki CM, George PM, Sies CW, Woods S. Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing. Ann Clin Biochem. 2008;45:535-538.
19. Kiesewetter S, Macek M, Davis C, et al. Amutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet. 1993;5:274-8.
20. Scotet V, Audrézet MP, Roussey M, Rault G, Dirou-Prigent A, Journel H, Moisan-Petit V, Storni V, Férec. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels? Pediatrics. 2006;118(5):1523-9.
21. Mayell SJ, Munck A, Craig JV, et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros. 2009;8:71-78.
22. Castellani C, Southern KW, Brownlee K, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009;8:153-173.